These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37646668)

  • 41. Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?
    Vályi-Nagy I; Uher F; Rákóczi É; Szekanecz Z
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection.
    Fiorcari S; Atene CG; Maffei R; Debbia G; Potenza L; Luppi M; Marasca R
    Haematologica; 2021 Aug; 106(8):2265-2268. PubMed ID: 33691383
    [No Abstract]   [Full Text] [Related]  

  • 43. Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages.
    Guo L; Zhang Q; Zhong J; Chen L; Jiang W; Huang T; Li Y; Zhang Y; Xu L; Wang X; Xiao Y; Wang Y; Dong X; Dong T; Peng Y; Zhang B; Xie Y; Gao H; Shen Z; Ren L; Cheng T; Wang J
    Emerg Microbes Infect; 2023 Dec; 12(1):2202263. PubMed ID: 37037791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants.
    Ju B; Zhang Q; Wang Z; Aw ZQ; Chen P; Zhou B; Wang R; Ge X; Lv Q; Cheng L; Zhang R; Wong YH; Chen H; Wang H; Shan S; Liao X; Shi X; Liu L; Chu JJH; Wang X; Zhang Z; Zhang L
    Nat Immunol; 2023 Apr; 24(4):690-699. PubMed ID: 36914890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies.
    Chang A; Akhtar A; Lai L; Orellana-Noia VM; Linderman SL; McCook-Veal AA; Switchenko JM; Saini M; Valanparambil RM; Blum KA; Allen PB; Lechowicz MJ; Romancik JT; Ayers A; Leal A; O'Leary CB; Churnetski MC; Baird K; Kives M; Wrammert J; Nooka AK; Koff JL; Dhodapkar MV; Suthar MS; Cohen JB; Ahmed R
    Cancer Res Commun; 2022 Dec; 2(12):1684-1692. PubMed ID: 36644323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia.
    Guisado-Vasco P; Carralón-González MM; Aguareles-Gorines J; Martí-Ballesteros EM; Sánchez-Manzano MD; Carnevali-Ruiz D; García-Coca M; Barrena-Puertas R; de Viedma RG; Luque-Pinilla JM; Sotres-Fernandez G; Fernández-Sousa JM; Luepke-Estefan XE; López-Martín JA; Jimeno JM
    J Hematol Oncol; 2022 Jan; 15(1):4. PubMed ID: 35012608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients.
    Del Poeta G; Bomben R; Polesel J; Rossi FM; Pozzo F; Zaina E; Cattarossi I; Varaschin P; Nanni P; Boschian Boschin R; Postorino M; Laureana R; Pasqualone G; Steffan A; Gentile M; Zucchetto A; Gattei V
    Hematol Oncol; 2021 Dec; 39(5):712-714. PubMed ID: 34462939
    [No Abstract]   [Full Text] [Related]  

  • 48. Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico.
    Montes-González JA; Zaragoza-Jiménez CA; Antonio-Villa NE; Fermín-Martínez CA; Ramírez-García D; Vargas-Vázquez A; Gutiérrez-Vargas RI; García-Rodríguez G; López-Gatell H; Valdés-Ferrer SI; Bello-Chavolla OY
    Front Public Health; 2023; 11():1146059. PubMed ID: 37081954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patients with CLL have a lower risk of death from COVID-19 in the Omicron era.
    Niemann CU; da Cunha-Bang C; Helleberg M; Ostrowski SR; Brieghel C
    Blood; 2022 Aug; 140(5):445-450. PubMed ID: 35588468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia: A Serologic and Cellular Study.
    Molica S; Giannarelli D; Lentini M; Zappala D; Mannella A; Loiacono D; Gianfelici V; Panduri G; Gariani I; Minchella P; Talarico F; Levato L
    Chemotherapy; 2022; 67(2):91-95. PubMed ID: 34872098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia.
    Merid Y; Tekleselasie W; Tesfaye E; Gadisa A; Fentahun D; Abate A; Alemu A; Mihret A; Mulu A; Gelanew T
    Front Immunol; 2023; 14():1163688. PubMed ID: 37398668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages.
    Xiang T; Wang J; Zheng X
    Virol Sin; 2022 Dec; 37(6):786-795. PubMed ID: 36427646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients.
    Blixt L; Bogdanovic G; Buggert M; Gao Y; Hober S; Healy K; Johansson H; Kjellander C; Mravinacova S; Muschiol S; Nilsson P; Palma M; Pin E; Smith CIE; Stromberg O; Sällberg Chen M; Zain R; Hansson L; Österborg A
    Leukemia; 2022 Feb; 36(2):476-481. PubMed ID: 34564699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.
    Tang J; Novak T; Hecker J; Grubbs G; Zahra FT; Bellusci L; Pourhashemi S; Chou J; Moffitt K; Halasa NB; Schwartz SP; Walker TC; Tarquinio KM; Zinter MS; Staat MA; Gertz SJ; Cvijanovich NZ; Schuster JE; Loftis LL; Coates BM; Mack EH; Irby K; Fitzgerald JC; Rowan CM; Kong M; Flori HR; Maddux AB; Shein SL; Crandall H; Hume JR; Hobbs CV; Tremoulet AH; Shimizu C; Burns JC; Chen SR; Moon HK; Lange C; Randolph AG; Khurana S
    Nat Commun; 2022 May; 13(1):2979. PubMed ID: 35624101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adaptive Immune Responses and Immunity to SARS-CoV-2.
    Primorac D; Vrdoljak K; Brlek P; Pavelić E; Molnar V; Matišić V; Erceg Ivkošić I; Parčina M
    Front Immunol; 2022; 13():848582. PubMed ID: 35603211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immunity in mice.
    Cheang NYZ; Tan KS; Tan PS; Purushotorma K; Yap WC; Tullett KM; Chua BYL; Yeoh AY; Tan CQH; Qian X; Chen H; Tay DJW; Caminschi I; Tan YJ; Macary PA; Tan CW; Lahoud MH; Alonso S
    Mol Ther; 2024 Jul; 32(7):2299-2315. PubMed ID: 38715364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Broadly Reactive SARS-CoV-2-Specific T-Cell Response and Participation of Memory B and T Cells in Patients with Omicron COVID-19 Infection.
    Yadav PD; Sahay RR; Salwe S; Trimbake D; Babar P; Sapkal GN; Deshpande GR; Bhise K; Shete AM; Abraham P; Tripathy AS
    J Immunol Res; 2023; 2023():8846953. PubMed ID: 37881339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.
    Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P
    Front Immunol; 2021; 12():797919. PubMed ID: 34975908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2.
    Luo M; Zhou B; Reddem ER; Tang B; Chen B; Zhou R; Liu H; Liu L; Katsamba PS; Au KK; Man HO; To KK; Yuen KY; Shapiro L; Dang S; Ho DD; Chen Z
    Emerg Microbes Infect; 2023 Dec; 12(1):2146538. PubMed ID: 36354024
    [No Abstract]   [Full Text] [Related]  

  • 60. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
    Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
    J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.